How We're Keeping You Safe | What Patients & Families Need to Know
The funding will be shared by a coordinating center and a network of 10 other top academic medical centers that will launch a five-year effort to improve genomic risk assessments for diverse populations and integrate their use in clinical care.
Researchers find that dose escalation of hydroxyurea treatment for children in Uganda with sickle cell anemia is more effective than a lower fixed dose of the same drug.
A transgenic mouse developed at Cincinnati Children’s to model the deadly childhood immune disease HLH (hemophagocytic lymphohistiocytosis) may play a key role in saving lives during the COVID-19 virus pandemic.
Selected as part of an international search that included a broad field of high-caliber candidates in pediatric medicine, Cheng comes from Johns Hopkins Hospital and the Johns Hopkins College of Medicine.
The projects, funded internally, will focus on developing vaccine nanoparticles, studying how the virus affects heart tissue, an artificial intelligence data analysis tool, and how COVID-19 affects foster youth, ADHD, and sickle cell disease.
Prompted by COVID-19 clinic closures, scientists developed the mail-in test so medically vulnerable patients can receive regular testing without the need for clinical visits.
Researchers report in the New England Journal of Medicine treating patients with a new drug called emapalumab that saves kid’s lives with less toxicity and fewer side effects.
Cincinnati Children’s is one of four sites in the U.S. participating in a Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19.
AI system uses pattern-recognizing machine learning and natural language processing (NLP) technologies to predict youth’s risk for committing actions of school violence.
New research in PLoS Pathogens suggests that reactivated Herpes Simplex Virus (HSV) in trigeminal nerves of laboratory mice kills off at least a portion of sensory neurons.
Cincinnati Children’s researchers report in Immunity the discovery of a complex biological process that helps underdeveloped lungs fight infections.
The Cincinnati Children's 2019 Research Annual Report features the most significant findings of the year from more than 50 research divisions.
A new study suggests that significant early childhood exposure to traffic-related air pollution (TRAP) is associated with structural changes in the brain at the age of 12.
Being the parent of a child with a life-altering chronic condition takes a psychological toll. For too many families, however, emotional and behavioral health support has been far too difficult to obtain.
New study demonstrates that many of the donor hearts deemed “high-risk” can be transplanted with the same survival rates as “low-risk” donor hearts.
Cincinnati Children’s Hospital has received a grant from the National Institute of Allergy and Infectious Diseases (NIAID) to continue as one of just nine federally funded centers to evaluate vaccines and treatments for infectious diseases.
Scientists describe in Nature Immunology an entirely new molecular process in mice that triggers T cell-driven inflammation and causes different autoimmune diseases.
Cincinnati Children’s researchers report in Nature that stem cell therapy helps hearts recover from heart attacks.
A study in Science Translational Medicine reports that Cincinnati Children’s researchers developed and successfully tested a new rapid blood assay that accurately predicts which patients are at low, medium or high risk for death from sepsis.
Bariatric surgery can have many benefits for severely obese teens, however, one of the two main types of procedures appears to lead to higher risk of long-term nutritional deficiencies.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462
© 1999-2020 Cincinnati Children's Hospital Medical Center. All rights reserved.